Hide Board Information

Show Board Information

Aberdeen Asia-Pacific Income Investment Co. Ltd. ABAKF

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/08/2014 4:24:09 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Aberdeen Asia-Pacific Income Investment Co. Ltd. ABAKF

Aberdeen Asia-Pacific Income Investment Co. Ltd. (OTCMRKTS: ABAKF) Stock Message Board

1. ABAKF Company Profile

    

2. ABAKF Time & Sales

    

3. ABAKF Recent News

    

4. ABAKF Filings

    

5. ABAKF Financials

    

6. ABAKF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	Latest Aberdeen Asia-Pc Inc (ABAKF) Headlines	Stock_Tracker	03/08/2014 4:24:09 PM
4	ABAKF 4.8655 Stock Charts $ABAKF 1 Month Chart	chartguy89	03/05/2014 5:37:35 PM
3	ABAKF Recent News Aberdeen Asia-Pacific Income	Stock_Tracker	03/01/2014 11:04:17 PM
2	ABAKF Stock Charts Friday, February 21, 2014 at	chartguy89	02/21/2014 11:32:36 PM
1	ABAKF Stock Chart 5.01 Saturday, February 8, 2014	chartguy89	02/08/2014 12:04:10 AM

Recent Articles

• Legal Action Launched for Kyverna Therapeutics Investors
• Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
• Haloid Enhances Safety in Film Productions with Reviews
• Insights on the Growing Demand for Edible Coatings in Produce
• Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
• Legal Update: Toronto-Dominion Bank Securities Class Action
• Key Updates from Nasdaq on the Nasdaq-100 Index Changes
• TeraBox Revolutionizes File Sharing with Free Unlimited Service
• Kessler Topaz Takes Action Against Enphase Energy for Fraud
• Demesne Resources Completes Second Tranche of Financing
• Spiro Celebrated as One of the Top Agencies in Marketing
• Global Uranium Corp. Launches Strategic Marketing Efforts
• UnitedHealth Group Clarifies Misconceptions and Updates Claims
• Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
• Acadia Healthcare Investors Urged to Take Action on Lawsuit
• Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
• Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
• Hola Prime's Innovative Vision: New Marketing Director Appointed
• Teamsters Advocate for Stronger Standards on Autonomous Vehicles
• BioVaxys Secures Funding and Enters Debt Settlement Agreement
• Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
• OFS Credit Company Shares November Net Asset Value Insights
• New FDA Approval for Crenessity Enhances CAH Treatment Options
• Q-Gold Secures Initial Funding for New Exploration Ventures
• Capital Power's Genesee Project Marks Major Energy Milestone
• Viridian Therapeutics Set to Present Veligrotug Results Soon
• Ensuring Safe Travels: King County's Holiday Traffic Initiative
• Acadia Healthcare Faces Class Action Amid Significant Losses
• S&P Dow Jones Indices Reveals Results of 2024 DJSI Review
• Celebrating Entrepreneurial Success: The Impact of MBDA
• Village Super Market's Dividend Announcement and Growth Plans
• Digi International Welcomes New Executive Leaders to Board
• Transfusion Market Expected to Rise by $2.6 Billion: Insights
• CenterPoint Energy Announces Increased Quarterly Dividend Payout
• Shobha Launches Exciting Offers and Convenient Memberships
• ANSC Secures Key Approval for Upcoming Business Combination
• Barite Market Forecast: Growth Driven by Oil and AI Trends
• Contract Cleaning Services: Driving Growth with AI Innovation
• Lochmere Association Recognized for Eco-Friendly Excellence
• Fairholme Funds Announcement: December Dividend Details
• Empowering Change: Vigil for Clemency at the White House
• Boar's Head Reaches Settlement in Landmark Listeria Case
• Discover the SR6800 Window: Where History Meets Innovation
• Turkish Airlines Announces New Lounge at JFK's Terminal One
• AI Innovations Fuel Growth in the Analytical Standards Market
• Understanding the Seafood Market: Trends and Innovations
• Univest Securities Completes $2.7 Million Offering for LICN
• CubeSmart Declares Quarterly Dividend Increase for Shareholders
• Douglas Emmett Inc. Announces Cash Dividend for Shareholders
• Galderma's Breakthrough Approval of Nemluvio for Atopic Dermatitis